Justin T Gass1, M Foster Olive. 1. Center for Drug and Alcohol Programs, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
Abstract
BACKGROUND: The perseverance of the motivational salience of drug-associated memories is an obstacle to the successful treatment of drug addiction and is often a causative factor in triggering relapse. METHODS: This study was intended to determine whether potentiation of type 5 metabotropic glutamate receptors (mGluR5), which are biochemically and structurally coupled to N-methyl-D-aspartate (NMDA) receptors, would facilitate the extinction of a cocaine-associated contextual memory as assessed by the conditioned place preference (CPP) paradigm in rats. Following the establishment of a cocaine CPP, rats were treated with the mGluR5 positive allosteric modulator 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB; 0.3, 3 and 30 mg/kg) before extinction test sessions. Additional groups of animals received 30 mg/kg CDPPB in combination with the mGluR5 antagonist 3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine (MTEP, 1 mg/kg) or the NMDA receptor antagonist MK-801 (.1 mg/kg). RESULTS: CDPPB dose-dependently facilitated the extinction of cocaine CPP, and these effects were not observed when animals were coadministered MTEP or MK-801. CDPPB failed to produce any evidence of neurotoxicity as assessed by FluoroJade C staining. CONCLUSIONS: Positive allosteric modulation of mGluR5 function facilitates the extinction of a cocaine-associated contextual memory, which may represent a novel approach toward enhancing extinction learning in the context of drug addiction.
BACKGROUND: The perseverance of the motivational salience of drug-associated memories is an obstacle to the successful treatment of drug addiction and is often a causative factor in triggering relapse. METHODS: This study was intended to determine whether potentiation of type 5 metabotropic glutamate receptors (mGluR5), which are biochemically and structurally coupled to N-methyl-D-aspartate (NMDA) receptors, would facilitate the extinction of a cocaine-associated contextual memory as assessed by the conditioned place preference (CPP) paradigm in rats. Following the establishment of a cocaine CPP, rats were treated with the mGluR5 positive allosteric modulator 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB; 0.3, 3 and 30 mg/kg) before extinction test sessions. Additional groups of animals received 30 mg/kg CDPPB in combination with the mGluR5 antagonist 3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine (MTEP, 1 mg/kg) or the NMDA receptor antagonist MK-801 (.1 mg/kg). RESULTS:CDPPB dose-dependently facilitated the extinction of cocaine CPP, and these effects were not observed when animals were coadministered MTEP or MK-801. CDPPB failed to produce any evidence of neurotoxicity as assessed by FluoroJade C staining. CONCLUSIONS: Positive allosteric modulation of mGluR5 function facilitates the extinction of a cocaine-associated contextual memory, which may represent a novel approach toward enhancing extinction learning in the context of drug addiction.
Authors: Arturo R Zavala; Suzanne M Weber; Heather J Rice; Andrea T Alleweireldt; Janet L Neisewander Journal: Brain Res Date: 2003-11-14 Impact factor: 3.252
Authors: Craig W Lindsley; David D Wisnoski; William H Leister; Julie A O'brien; Wei Lemaire; David L Williams; Maryann Burno; Cyrille Sur; Gene G Kinney; Doug J Pettibone; Philip R Tiller; Sheri Smith; Mark E Duggan; George D Hartman; P Jeffrey Conn; Joel R Huff Journal: J Med Chem Date: 2004-11-18 Impact factor: 7.446
Authors: Feng Liu; Steve Grauer; Cody Kelley; Rachel Navarra; Radka Graf; Guoming Zhang; Peter J Atkinson; Michael Popiolek; Caitlin Wantuch; Xavier Khawaja; Deborah Smith; Michael Olsen; Evguenia Kouranova; Margaret Lai; Farhana Pruthi; Claudine Pulicicchio; Mark Day; Adam Gilbert; Mark H Pausch; Nicholas J Brandon; Chad E Beyer; Tom A Comery; Sheree Logue; Sharon Rosenzweig-Lipson; Karen L Marquis Journal: J Pharmacol Exp Ther Date: 2008-08-27 Impact factor: 4.030
Authors: Alice L Rodriguez; Mark D Grier; Carrie K Jones; Elizabeth J Herman; Alexander S Kane; Randy L Smith; Richard Williams; Ya Zhou; Joy E Marlo; Emily L Days; Tasha N Blatt; Satyawan Jadhav; Usha N Menon; Paige N Vinson; Jerri M Rook; Shaun R Stauffer; Colleen M Niswender; Craig W Lindsley; C David Weaver; P Jeffrey Conn Journal: Mol Pharmacol Date: 2010-10-05 Impact factor: 4.436
Authors: S W Fowler; A K Ramsey; J M Walker; P Serfozo; M F Olive; T R Schachtman; A Simonyi Journal: Neurobiol Learn Mem Date: 2010-11-17 Impact factor: 2.877
Authors: S B Taylor; L R Watterson; P R Kufahl; N E Nemirovsky; S E Tomek; C D Conrad; M F Olive Journal: Neuropharmacology Date: 2016-05-07 Impact factor: 5.250
Authors: David J Loane; Bogdan A Stoica; Flaubert Tchantchou; Alok Kumar; James P Barrett; Titilola Akintola; Fengtian Xue; P Jeffrey Conn; Alan I Faden Journal: Neurotherapeutics Date: 2014-10 Impact factor: 7.620